Celebrating International Women's Day with Special Offers from CDR Journal!
Today, we joyfully commemorate the remarkable achievements, resilience, and contributions of women worldwide. As we mark this special occasion, the Editorial Office of Cancer Drug Resistance (CDR) extends heartfelt appreciation to each and every one of you for your invaluable role in shaping the landscape of cancer drug resistance research.
On this International Women's Day, let us reaffirm our commitment to gender equality, diversity, and inclusivity in academia and beyond. Together, let us continue to empower, uplift, and support one another as we strive to make a meaningful impact in the fight against cancer.
In honor of International Women's Day 2024, the CDR Editorial Office is pleased to announce a special promotion: a 20% discount on APCs for each article with a female first or corresponding author. This initiative is our tribute to the outstanding contributions of women researchers in our field.
If you would like to contribute to our CDR journal, please send your manuscript title, type, abstract, and authors to the CDR Editorial Office by April 30, 2024, at editorial@cdrjournal.com.
*All submissions must fall within the scope of the journal and undergo peer review.
Additionally, we are actively seeking female researchers in the field of cancer drug resistance to join the CDR Editorial Board or the CDR Junior Editorial Board.
*Please download and fill in the CDR Editorial Board Application Form provided below, and submit it to the journal's Editorial Office at editorial@cdrjournal.com with the subject line "CDR Editorial Board/Young Editor Application + Your Name".
CDR Editorial Board Application Form:
https://oaepublishstorage.blob.core.windows.net/uploadedfiles/Application-Form-for-Editorial-Board-Member-of-Cancer-Drug-Resistance-(CDR).-doc.doc
Thank you for your unwavering dedication, perseverance, and brilliance. Your contributions are invaluable, and your voices are essential in shaping the future of cancer drug resistance research.
Editor: Louise Pan
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully submitted by the Editorial Office of Cancer Drug Resistance.
